Skip to main content
. 2017 Nov 9;2017(11):CD011770. doi: 10.1002/14651858.CD011770.pub2

Comparison 11. Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Overall incidence of block‐related adverse events 5 393 Risk Ratio (M‐H, Random, 95% CI) 1.09 [0.69, 1.70]
2 Numbness/tingling 14 days after surgery 2 101 Risk Ratio (M‐H, Random, 95% CI) 1.69 [0.31, 9.26]
3 Residual motor block/muscle weakness 24 hours after surgery 3 265 Risk Ratio (M‐H, Random, 95% CI) 2.68 [0.80, 8.90]
4 Horner syndrome 2 214 Risk Ratio (M‐H, Random, 95% CI) 0.89 [0.63, 1.26]
5 Hoarsenss 2 215 Risk Ratio (M‐H, Random, 95% CI) 0.88 [0.45, 1.71]
6 Dyspnoea 3 219 Risk Ratio (M‐H, Random, 95% CI) 0.63 [0.11, 3.74]
7 Cranial nerve 12 palsy 1 78 Risk Ratio (M‐H, Random, 95% CI) 0.37 [0.02, 8.77]
8 Overall non‐block‐related adverse events 5 258 Risk Ratio (M‐H, Random, 95% CI) 1.23 [0.38, 3.97]
9 Postoperative nausea and vomiting 3 134 Risk Ratio (M‐H, Random, 95% CI) 0.66 [0.12, 3.78]
10 Dermatological symptoms 2 124 Risk Ratio (M‐H, Random, 95% CI) 1.88 [0.09, 40.62]
11 Dizziness/wrist, hand or finger pain, constipation 1 78 Risk Ratio (M‐H, Random, 95% CI) 0.37 [0.02, 8.77]